m+Medelevator.RU
← Поиск публикаций
Journal of medicinal chemistry · 2025

Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Velcicky Juraj, Langlois Jean-Baptiste, Wright Michael, Janser Philipp, Angst Daniela, Arnold Christelle, Beltz Karen, Brenneisen Silke, Dubois Celine, Dawson Janet, Fischer Christian, Gommermann Nina, Heizmann Andreas, Ilic Slavica, Machauer Rainer, Maschlej Magdalena, Monnerat Sarah, Pflieger Daniel, Ristov Jacinda, Rubert Joelle, Schwalm Günther, Smith Daniel R, Srinivas Honnappa, Steiner Roland, Stojanovic Aleksandar, Troxler Thomas, Unterreiner Adeline, Vangrevelinghe Eric, von Burg Nicole, Wunderlich Jennifer, Farady Christopher J, Mackay Angela

Аннотация

NLRP3 is a molecular sensor present in innate immune cells which recognizes a variety of danger signals such as MSU, ATP, or Aβ. Upon activation, it seeds a protein complex termed the inflammasome, which leads to secretion of the proinflammatory cytokines IL-1β and IL-18 and initiates pyroptotic cell death. NLRP3 inflammasome activation has been associated with a wide range of diseases including atherosclerosis, gout, and cancer. In this publication, we describe the replacement of the phenol moiety with indoles in the recently described pyridazine scaffold. This replacement required a shift of the hydrogen bond donor from the "ortho" to the "meta" position, relative to the pyridazine ring. Initial indole analog 7 demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. Decreasing lipophilicity led to the discovery of NP3-742, demonstrating a favorable overall profile including diminished hERG inhibition and in vivo efficacy in a mouse peritonitis model.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты